$Clarivate (CLVT.US)$Since its listing in 2018, the company'...

$Clarivate (CLVT.US)$Since its listing in 2018, the company's revenue has grown rapidly for 5 years, and operating profit has also turned from loss to profit. However, net income has continued to be impacted by high interest expenses and remains in a loss. In 2022, there is also a 4.45 billion capital asset impairment, which should be the result of previous acquisitions. It does not have investment value temporarily.